300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Canada
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Barbados
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
NJTC Venture Fund, VC Fund

NJTC Venture Fund

VC Fund

Mount Laurel, United States

NJTC Venture Fund is a VC fund in Mount Laurel focused on Software and Health Care. As of 2008 NJTC Venture Fund is no longer an active investor. NJTC Venture Fund made catalytic seed, startup, and early stage venture capital investments. The firm actively partners with entrepreneurs to build unique, leading-edge businesses that drive superior returns for investors and economic growth in the community.

Total investments:
25
Last investment:
Lead investor:
28%

Last updated:

Industries NJTC Venture Fund invests in

SoftwareHealth CareBiotechnologyInformation TechnologyComputer

Stages NJTC Venture Fund invests in

Series BSeries ASeries CFunding RoundGrant

Countries NJTC Venture Fund invests in

United States

Contacts

NameEmailPhoneSocials
Colleen Algayer
Jim Gunton Jim Gunton
Joseph Falkenstein Joseph Falkenstein
Robert Chefitz Robert Chefitz

Sign up to unlock verified contacts

Unlock Contacts

1 more contact available

Investment Focus

Industry

  • Software 9 (36%)
  • Health Care 4 (16%)
  • Biotechnology 3 (12%)
  • Information Technology 3 (12%)
  • Computer 2 (8%)
See all 33 industries →

Stage

  • Series B 8 (32%)
  • Series A 6 (24%)
  • Series C 3 (12%)
  • Funding Round 3 (12%)
  • Grant 1 (4%)

Team

NameTitleInvestmentsLinksEmail
Colleen Algayer Office Manager
Office Manager Total investments: 0
Find email
Jim Gunton
Jim Gunton General Partner
General Partner Total investments: 8
Find email
Joseph Falkenstein
Joseph Falkenstein General Partner
General Partner Total investments: 0
Find email
Robert Chefitz
Robert Chefitz Founder & General Partner
Founder & General Partner Total investments: 9
Find email

Investments

CompanyDescriptionRoundLinks
InstaMed InstaMed
InstaMed provides healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumersatisfaction. $17M / Dec 03, 2014
SunRay Scientific Inc. SunRay Scientific Inc.
SunRay Scientific (SRS) is a supplier of advanced materials for printed electronics manufacturing and lead free packaging. The company’s key focus is the advancement of green electronics with clean chemistry, which includes development of conductive inks, epoxies and anisotropic conductive adhesives that minimize waste, eliminate use of lead, andreduce carbon footprint in electronics manufacturing. Grant / Dec 07, 2010
InstaMed InstaMed
InstaMed provides healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumersatisfaction. $6M / Sep 15, 2010
InstaMed InstaMed
InstaMed provides healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumersatisfaction. $6M / Mar 17, 2009
Archive Systems Archive Systems
At Archive Systems, their vision is to change the way organizations view document processing by enabling them to virtualize the back office. The company was founded in 1991 to address the demands of businesses overwhelmed with paper and seeking a records storage company to solve their paper storage issues. In 1998, they pioneered the firstservices-based, on-demand document management solution, ASPEN 360. The Virtual File Room Edition allows organizations to image and access a wide range of content including HR employee records and I-9 forms as well as legal documents and leases.The product includes ASPEN 360 Paper Virtualization Center, which removes from the client all tasks associated with document imaging, data capture, document classification, indexing, and OCR. Their records management services include everything from business records storage and document shredding to offsite data storage and document conversion. With a network of owned and operated Record Centers complete with barcode tracking, system-driven workflows and sophisticated records management systems, they ensure that your records are well protected, yet easily accessible when needed. $11.5M / Series B / Jun 26, 2007
InstaMed InstaMed
InstaMed provides healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumersatisfaction. $6.5M / Apr 27, 2007
Gaia Power Technologies Gaia Power Technologies
Gaia Power Technologies, Inc. provides distributed energy management and storage systems in the United States. The company offers PowerTower, a backup power system that provides power for homes and businesses. It offers its products through resellers and distributors. Gaia Power Technologies, Inc. was founded in 2002 and is headquartered in NewYork, New York. $2.9M / Series B / Mar 12, 2007
Viracor-IBT Laboratories Viracor-IBT Laboratories
Viracor-IBT Laboratories is dedicated to being the leading specialty diagnostics laboratory partner in allergy, immunology, and infectious disease testing.They provide doctors and hospitals the tests, results and support they need to deliver the best care possible, and they collaborate with pharmaceutical researchers to solve difficult problemsand accelerate drug development. $20.5M / Series C / Mar 07, 2007
Sword Diagnostics Sword Diagnostics
Sword Diagnostics is a leading-edge life sciences company created in response to the rapidly evolving needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable toeffectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. $1.5M / Series B / Mar 05, 2007
Sword Diagnostics Sword Diagnostics
Sword Diagnostics is a leading-edge life sciences company created in response to the rapidly evolving needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable toeffectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. $1.6M / Series A / Oct 13, 2006
See all 25 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Canada
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Barbados
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does NJTC Venture Fund invest in?

NJTC Venture Fund invests primarily in Software, Health Care and Biotechnology startups, most often at Series B and Series A stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact NJTC Venture Fund?

Public channels for NJTC Venture Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at NJTC Venture Fund?

The team at NJTC Venture Fund includes Colleen Algayer (Office Manager), Jim Gunton (General Partner) and Joseph Falkenstein (General Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
NJTC Venture Fund NJTC Venture Fund Find emails